BACKGROUND: Gold and carbon nanoparticles absorb nonionizing radio frequency (RF) energy and release heat. Solid gold nanoparticles are delivered to cancer cells via conjugation with targeting antibodies. Here, 20-nm gold particles were conjugated to cetuximab, which is an epidermal growth factor receptor-1 (EGFR-1) antibody. METHODS: A pancreatic carcinoma cell line that highly expresses EGFR-1, Panc-1, and Cama-1, which is a breast carcinoma cell line that minimally expresses EGFR-1, were treated with 100-nmol/L cetuximab-conjugated gold nanoparticles for 3 h (n = 4). Thirty-six hours later, the dishes were placed in an RF field with a generator power of 200 W for 5 min. After another 36 h, cell injury and death were evaluated with flow cytometry. RESULTS: The targeted cell line Panc-1 had a viability of 46% +/- 12%, whereas the Cama-1 cell had a viability of 92% +/- 2% after RF field exposure (P < .008). Transmission electron microscopy showed gold nanoparticle uptake in Panc-1 cells but negligible uptake by Cama-1 cells. Nontargeted cells do not internalize a sufficient amount of antibody-conjugated gold nanoparticles to induce injury in a noninvasive RF field. CONCLUSION: This technique could be useful in cancer treatment if a cancer-specific antibody is used to localize gold nanoparticles to malignant cells. Copyright 2010 Mosby, Inc. All rights reserved.
BACKGROUND: Gold and carbon nanoparticles absorb nonionizing radio frequency (RF) energy and release heat. Solid gold nanoparticles are delivered to cancer cells via conjugation with targeting antibodies. Here, 20-nm gold particles were conjugated to cetuximab, which is an epidermal growth factor receptor-1 (EGFR-1) antibody. METHODS: A pancreatic carcinoma cell line that highly expresses EGFR-1, Panc-1, and Cama-1, which is a breast carcinoma cell line that minimally expresses EGFR-1, were treated with 100-nmol/L cetuximab-conjugated gold nanoparticles for 3 h (n = 4). Thirty-six hours later, the dishes were placed in an RF field with a generator power of 200 W for 5 min. After another 36 h, cell injury and death were evaluated with flow cytometry. RESULTS: The targeted cell line Panc-1 had a viability of 46% +/- 12%, whereas the Cama-1 cell had a viability of 92% +/- 2% after RF field exposure (P < .008). Transmission electron microscopy showed gold nanoparticle uptake in Panc-1 cells but negligible uptake by Cama-1 cells. Nontargeted cells do not internalize a sufficient amount of antibody-conjugated gold nanoparticles to induce injury in a noninvasive RF field. CONCLUSION: This technique could be useful in cancer treatment if a cancer-specific antibody is used to localize gold nanoparticles to malignant cells. Copyright 2010 Mosby, Inc. All rights reserved.
Authors: Jussuf T Kaifi; Uta Reichelt; Alexander Quaas; Paulus G Schurr; Robin Wachowiak; Emre F Yekebas; Tim Strate; Claus Schneider; Klaus Pantel; Melitta Schachner; Guido Sauter; Jakob R Izbicki Journal: Mod Pathol Date: 2007-09-14 Impact factor: 7.842
Authors: Jon A Schwartz; Anil M Shetty; Roger E Price; R Jason Stafford; James C Wang; Rajesh K Uthamanthil; Kevin Pham; Roger J McNichols; Chris L Coleman; J Donald Payne Journal: Cancer Res Date: 2009-02-10 Impact factor: 12.701
Authors: N J Lygidakis; Sandesh K Sharma; P Papastratis; Vladimir Zivanovic; H Kefalourous; Mahim Koshariya; I Lintzeris; T Porfiris; D Koutsiouroumba Journal: Hepatogastroenterology Date: 2007 Jul-Aug
Authors: Warna D Kaluarachchi; Brandon T Cisneros; Stuart J Corr; Nathaniel D Albert; Steven A Curley; Dimitrios P Kontoyiannis Journal: Antimicrob Agents Chemother Date: 2013-07-08 Impact factor: 5.191
Authors: Jason C Ho; Lam Nguyen; Justin J Law; Matthew J Ware; V Keshishian; N C Lara; Trac Nguyen; Steven A Curley; Stuart J Corr Journal: IEEE J Transl Eng Health Med Date: 2017-04-03 Impact factor: 3.316
Authors: Dustin E Kruse; Douglas N Stephens; Heather A Lindfors; Elizabeth S Ingham; Eric E Paoli; Katherine W Ferrara Journal: IEEE Trans Biomed Eng Date: 2011-03-10 Impact factor: 4.538